The Food and Drug Administration declared an end to the scarcity of Eli Lilly’s highly in-demand weight-loss and diabetes drugs on Thursday.
Our daily email brings you smart and engaging news and analysis on the biggest stories in business and finance. For free.
In the obesity drug industry, two players have really been throwing their weight around. There isn’t a third in sight.
WW announced on Thursday that it will be laying off employees and cutting costs to the tune of $100 million per year.
Novo Nordisk on Wednesday announced an expanded deal with healthtech firm Valo Health to use AI to fuel drug discovery.
A spill of new data Wednesday sent oil futures slipping and sliding in opposite directions. So is Big Oil’s tank is half-full or half-empty?
On Tuesday, the overall yield on the US 10-Year Treasury Bond touched its highest intraday point, 4.699%, since last spring.